Biggest News Aggregation in the World
📰 Molecule Type News

Page 2 - Molecule Type News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Molecule Type. Real-time updates on events, politics, business and more.

Medullary Thyroid Cancer Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)

DelveInsights Medullary Thyroid Cancer Pipeline Insight 2023 report provides comprehensive global Medullary Thyroid Cancer coverage of available, marketed, and Medullary Thyroid Cancer Pipeline...
United States Las Vegas Caprelsa Bayer Selpercatinib Takeda Yash Bhardwaj Bristol Myers Squibb Regorafenib

Cryopyrin-Associated Periodic Syndrome Pipeline, Clinical Trials Studies, Emerging Drugs, Mergers and Acquisition, Licensing, Agreements & Collaborations, and Latest News 2023 (Updated)

DelveInsights, Cryopyrin-Associated Periodic Syndrome Pipeline Insight 2023 report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Cryopyrin-Associated Periodic Syndrome ...
United States Las Vegas Zydus Cadila Yash Bhardwaj Periodic Syndrome Companies Zydus Cadila Regeneron Pharmaceuticals

Propulsion of Sarcopenia Clinical Trial Pipeline as Novel and Extensive 10+ Therapies Likely to Enter in the Domain | DelveInsight

(Albany, United States) As per DelveInsight’s assessment, globally, the Sarcopenia Pipeline constitutes 8+ key companies continuously working towards developing 10+ Sarcopenia Pipeline treatment therapies, analysis
United States Las Vegas Yash Bhardwaj Merck Sharp Dohme Delveinsight Business Research Regeneron Pharmaceuticals

Propulsion of Acne Vulgaris Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight

(Albany, United States) As per DelveInsight’s assessment, globally, the Acne Vulgaris Pipeline constitutes 22+ key companies continuously working towards developing 22+ Acne Vulgaris Pipeline treatment therapies,
United States Eligo Bioscience Las Vegas Fudan Zhangjiang Bio Yash Bhardwaj Kintor Pharma

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Propulsion of Amyotrophic Lateral Sclerosis Clinical Trial Pipeline as Novel and Extensive 100+ Therapies Likely to Enter in the Domain | DelveInsight

(Albany, United States) As per DelveInsight’s assessment, globally, the Amyotrophic Lateral Sclerosis Pipeline constitutes 90+ key companies continuously working towards developing 100+ Amyotrophic Lateral
United States Ferrer Internacional Clene Nanomedicine Inflectis Bioscience Knopp Biosciences Lou Gehrig

Geological Shifts in Lung Cancer Therapeutics Market: Unveiling Growth Triggers Propelling a 13.4% C

It is expected that the global Lung Cancer Therapeutics Market will prosper during the forecast period, growing at a total CAGR of 13.4% from 2022 to 2032. By 2026, it is anticipated that the global market would be worth US$ 48,725.9 million. The lung cancer therapeutics market is anticipated to grow along with incr...
New York United States Asia Pacific Boehringer Ingelheim Gmb Eli Lilly Lung Disease Research Funding

Propulsion of PCSK9 Inhibitor Clinical Trial Pipeline as Novel and Extensive 14+ Therapies Likely to Enter in the Domain | DelveInsight

(Albany, United States) As per DelveInsight’s assessment, globally, the PCSK9 Inhibitor Pipeline constitutes 14+ key companies continuously working towards developing 14+ PCSK9 Inhibitor Pipeline treatment
United States Las Vegas Akeso Biopharma Evolocumab Repatha Yash Bhardwaj Proprotein Convertase Subtilisin Kexin

Propulsion of Hyperphosphatemia Clinical Trial Pipeline as Novel and Extensive 15+ Therapies Likely to Enter in the Domain | DelveInsight

(Albany, United States) As per DelveInsight’s assessment, globally, the Hyperphosphatemia Pipeline constitutes 15+ key companies continuously working towards developing 15+ Hyperphosphatemia Pipeline treatment
United States Yash Bhardwaj Las Vegas Daiichi Sankyo Nuokang Bio Panion Bf Biotech Inc

Propulsion of Hepatorenal Syndrome Clinical Trial Pipeline as Novel and Extensive 3+ Therapies Likely to Enter in the Domain | DelveInsight

(Albany, United States) As per DelveInsight’s assessment, globally, the Hepatorenal Syndrome Pipeline constitutes 3+ key companies continuously working towards developing 3+ Hepatorenal Syndrome Pipeline treatment
United States Yash Bhardwaj Las Vegas Route Of Administration Hepatorenal Syndrome Key Companies Company Name

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science